PANews, March 15: 10x Research posted on X that its quantitative model has generated its strongest altcoin buy signal since October 2025, with Bittensor (TAO) showing particularly strong performance. Its price has now risen above both the 7-day and 30-day moving averages, posting a nearly 38.6% gain in just one week. Analysts attribute part of this rally to news that NVIDIA plans to launch NemoClaw, an open-source autonomous AI agent platform, as well as to General Tensor, an AI computing network ecosystem company, completing a $5 million funding round, which further boosted market sentiment. Bittensor’s network has recently transitioned to a Nominated Proof of Stake (NPoS) mechanism, which is expected to enhance network operational efficiency. As institutional capital increasingly focuses on exposure to “productive” AI infrastructure, trading volumes for AI-related tokens have risen significantly.
10x Research: AI Sector Crypto Assets Show Strong Buy Signals, TAO Rises 38.6%
PANewsShare
Summary
10x Research observed a strong altcoin buy signal on March 15, with Bittensor (TAO) leading the movement. TAO’s price has surged 38.6% in one week, rising above its 7-day and 30-day moving averages. The rally follows NVIDIA’s NemoClaw announcement and General Tensor’s $5 million funding round. Bittensor’s transition to Nominated Proof of Stake has further enhanced efficiency. AI-focused tokens are attracting growing institutional interest and higher trading volumes.
Source:Show original
Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information.
Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.